Ivosidenib in predominantly recurrent IDH1-mutant glioma: A single-institution experience

Ivosidenib in predominantly recurrent IDH1-mutant glioma: A single-institution experience

June 15, 2026 · 16 min

About this episode

Dr. John Fortunato interviews Dr. Sofia Rael and Dr. Ugur Sener about their manuscript on Ivosidenib in recurrent IDH1-mutant glioma.

Podcast Host and Interviewee: Host: John Fortunato Interviewee: Sofia Rael, Ugur Sener Podcast Description: Dr. John Fortunato interviews Dr. Sofia Rael and Dr. Ugur Sener on their recent manuscript, titled " Ivosidenib in predominantly recurrent IDH1-mutant glioma: A single institution experience."

People in this episode

Host: John Fortunato

Guests: Sofia Rael, Ugur Sener

Topics covered

Mentioned in this episode

Books & works: Ivosidenib in predominantly recurrent IDH1-mutant glioma: A single institution experience

More episodes of Neuro-Oncology: The Podcast

Explore listener stats, chart rankings, contacts and more on the Neuro-Oncology: The Podcast podcast page.